Butene concentration prediction in ethylene/propylene/1-butene terpolymers by FT-IR spectroscopy through multivariate statistical analysis and artificial neural networksMARENGO, Emilio; LONGO, Valentina; BOBBA, Marco et al.Talanta (Oxford). 2009, Vol 77, Num 3, pp 1111-1119, issn 0039-9140, 9 p.Article

Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance)SHULMAN, Lawrence N; BERRY, Donald A; BURSTEIN, Harold J et al.Journal of clinical oncology. 2014, Vol 32, Num 22, pp 2311-2317, issn 0732-183X, 7 p.Article

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2⁺ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831DUECK, Amylou C; REINHOLZ, Monica M; MARTINO, Silvana et al.Clinical cancer research (Print). 2013, Vol 19, Num 20, pp 5798-5807, issn 1078-0432, 10 p.Article

A Randomized Trial of Oral Betamethasone to Reduce Ataxia Symptoms in Ataxia Telangiectasia online videoZANNOLLI, Raffaella; BUONI, Sabrina; MICHELI, Roberto et al.Movement disorders. 2012, Vol 27, Num 10, pp 1312-1316, issn 0885-3185, 5 p.Article

A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)ZULIAN, Francesco; VALLONGO, Cristina; PATRIZI, Annalisa et al.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 6, pp 1151-1156, issn 0190-9622, 6 p.Article

Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen : NCIC CTG Intergroup Trial MA. 17MUSS, Hyman B; DONGSHENG TU; PRITCHARD, Kathleen I et al.Journal of clinical oncology. 2008, Vol 26, Num 12, pp 1956-1964, issn 0732-183X, 9 p.Article

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen : A companion study to NCIC CTG MA.17PEREZ, Edith A; JOSSE, Robert G; SHIFANG LIU et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3629-3635, issn 0732-183X, 7 p.Article

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trialINGLE, James N; DONGSHENG TU; LIVINGSTON, Robert B et al.Breast cancer research and treatment. 2006, Vol 99, Num 3, pp 295-300, issn 0167-6806, 6 p.Article

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741CITRON, Marc L; BERRY, Donald A; PEREZ, Edith A et al.Journal of clinical oncology. 2003, Vol 21, Num 8, pp 1431-1439, issn 0732-183X, 9 p.Article

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 TrialPEREZ, Edith A; DUECK, Amylou C; KUTTEH, Leila A et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2115-2122, issn 0732-183X, 8 p.Article

Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy TrialSPARANO, Joseph A; MOLIN WANG; WOOD, William C et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 5, pp 406-414, issn 0027-8874, 9 p.Article

Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101SHULMAN, Lawrence N; CIRRINCIONE, Constance T; KIMMICK, Gretchen et al.Journal of clinical oncology. 2012, Vol 30, Num 33, pp 4071-4076, issn 0732-183X, 6 p.Article

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerSPARANO, Joseph A; GOLDSTEIN, Lori J; SHULMAN, Lawrence N et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7693-7700, issn 1078-0432, 8 p.Article

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer TrialPEREZ, Edith A; SUMAN, Vera J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1231-1238, issn 0732-183X, 8 p.Article

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer : Final analysis from INT-0137 (s9313)LINDEN, Hannah M; HASKELL, Charles M; MARTINO, Silvana et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 656-661, issn 0732-183X, 6 p.Article

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancerBERRY, Donald A; CIRRINCIONE, Constance; HUDIS, Clifford et al.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 14, pp 1658-1667, issn 0098-7484, 10 p.Article

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer : Updated findings from NCIC CTG MA.17GOSS, Paul E; INGLE, James N; LIVINGSTON, Robert B et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 17, pp 1262-1271, issn 0027-8874, 10 p.Article

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer : Treatment results of intergroup protocol INT-0102HUTCHINS, Laura F; GREEN, Stephanie J; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8313-8321, issn 0732-183X, 9 p.Conference Paper

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)LARA, Jonathan F; THOR, Ann D; CRAIG HENDERSON, I et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5170-5178, issn 1078-0432, 9 p.Article

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)SLOVAK, Marilyn L; BEDELL, Victoria; STOCK, Wendy et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 391-398, issn 0167-6806, 8 p.Article

Gene Polymorphisms in Cyclophosphamide Metabolism Pathway, Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast CancerSONG YAO; BARLOW, William E; RAVDIN, Peter M et al.Clinical cancer research (Print). 2010, Vol 16, Num 24, pp 6169-6176, issn 1078-0432, 8 p.Article

Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical TrialCHOI, Ji-Yeob; BARLOW, William E; RAVDIN, Peter M et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5258-5266, issn 1078-0432, 9 p.Article

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831HALYARD, Michele Y; PISANSKY, Thomas M; KUTTEH, Leila et al.Journal of clinical oncology. 2009, Vol 27, Num 16, pp 2638-2644, issn 0732-183X, 7 p.Article

Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease : An Italian multicenter studyMARTIRE, Baldassarre; RONDELLI, Roberto; DELLEPIANE, Rosa M et al.Clinical immunology (Orlando, Fla. Print). 2008, Vol 126, Num 2, pp 155-164, issn 1521-6616, 10 p.Article